Two Sigma Securities, LLC Chembio Diagnostics, Inc. Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.25 - $0.45 $4,761 - $8,571	-19,047 Reduced 50.88%	18,391 $8,000
Q4 2022 Feb 14, 2023	BUY	$0.2 - $0.33 $2,870 - $4,736	14,353 Added 62.17%	37,438 $8,000
Q3 2022 Nov 14, 2022	SELL	$0.35 - $1.1 $8,036 - $25,257	-22,961 Reduced 49.87%	23,085 $8,000
Q2 2022 Aug 15, 2022	BUY	$0.45 - $0.8 $20,720 - $36,836	46,046 New	46,046 $30,000
Q1 2022 May 16, 2022	SELL	$0.66 - $1.23 $23,697 - $44,163	-35,905 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.09 - $2.55 $39,136 - $91,557	35,905 New	35,905 $41,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.